Related by context. All words. (Click for frequent words.) 72 Isis Pharma 71 Inspire Pharma 69 Regeneron Pharma 69 OSI Pharma 69 Revises FY# Outlook 69 Rheumatoid Arthritis Drug 69 Idenix Pharma 69 Backs FY# Outlook 69 VIVUS VVUS 68 Penwest Pharma 68 Metabasis Therapeutics 68 Reaffirms FY# Outlook 68 Submits NDA 68 Auxilium Pharma 68 Optimer Pharma 68 MBRX 68 Angiotech Pharma 68 Lifts FY# Outlook 68 Lifts FY# Guidance 68 Backs FY# View 68 Reaffirms FY# Guidance 68 Reiterates FY# Outlook 68 DOV Pharmaceutical 68 Drug Fails 67 Backs FY# Forecast 67 Completes Patient Enrollment 67 Gout Drug 67 Receives Approvable Letter 67 NGSX 67 Initiates Phase III 67 Lupus Drug 67 Revises FY# Guidance 67 Milestone Payment 67 Salix Pharma 67 ARYX 67 Psoriasis Drug 67 Backs FY# Guidance 66 Therapeutic Competitors companiesandmarkets.com adEgemonye 66 Arthritis Drug 66 Q3 Profit Decreases 66 Migraine Drug 66 Generic Version Of 66 PHRM 66 Array BioPharma ARRY 66 Lifts FY# View 66 Sunesis Pharma 66 Initiates Clinical 66 Rigel Pharmaceuticals 66 FDA Approvals 66 Guides FY# FY# 66 Launches Generic Version 66 FDA Approves Generic 66 DOV Pharmaceutical Inc. 66 Auxilium Pharmaceuticals AUXL 65 Initiates Clinical Trial 65 Milestone Payments 65 Keryx Biopharma 65 Nicotine Vaccine 65 Weight Loss Drug 65 FDA Okays 65 Lung Cancer Drug 65 Teva Pharm 65 Announces Tentative Approval 65 FDA APPROVES 65 Teva Pharma 65 Transcept Pharmaceuticals 65 Vertex Pharma 65 Receive Milestone Payment 65 Cubist Pharma 65 Taro Receives 65 Mylan Receives Approval 65 Therapeutic Competitors Companies 65 Schizophrenia Treatment 65 Seattle Genetics SGEN 64 Initiates Enrollment 64 Lifts FY# Forecast 64 Receives CE Marking 64 Achieves Primary Endpoint 64 NDA Submission 64 Employment Inducement Awards 64 LGND 64 Beats Raises Guidance 64 Meets Primary Endpoint 64 IG HCR ;) CO 64 Mg Usa 64 BioCryst Pharma 64 Phase IIb Trial 64 Par Pharma 64 Corautus Genetics 64 Successfully Completes Phase 64 Indevus Pharma 64 Phase 2a Trial 64 Febuxostat 64 DOV Pharmaceuticals 64 Alexion Pharma 64 Licenses Novel 64 Phase 2b Trial 64 Therapeutic Competitors Report 64 Risperidone Oral Solution 63 NPS Pharma 63 MEDW 63 ACADIA Pharmaceuticals 63 Vertex hepatitis C 63 EPS Beats Estimate 63 Q4 Profit Climbs 63 Lowers FY# Outlook 63 Initiates Phase II 63 Begins Dosing 63 Naprelan R 63 Earns Milestone Payment 63 Submits Response 63 FY# EPS View 63 DVT prophylaxis cholesterol 63 Diamyd Medical Diamyd 63 Backs FY# 63 Presents Positive 63 Viagra Soft Cialis Soft 63 Antidepressant Drug 63 VIVUS Announces 63 Glufosfamide 63 Generic Protonix 63 Immunomedics Announces 63 Q2 Profit Decreases 63 Vicriviroc 63 sumatriptan succinate injection 63 Generic Version 63 Stock Buyback Plan 63 Clinical Trial Enrollment 63 Protalix BioTherapeutics PLX 63 CRTX 63 Demonstrates Positive 63 NASDAQ VVUS 63 Momenta Pharmaceuticals MNTA 63 Canaccord Genuity Reiterates Buy 63 Initiate Clinical Trial 63 Nanophase Announces 63 inhalation aerosol 63 NOVN 63 NASDAQ ONXX 63 Celgene Thalomid 63 Demonstrates Significant 63 PRAECIS PHARMACEUTICALS INCORPORATED 63 Files IND 63 Announcement acc 63 Cholesterol Drug 62 ARQL 62 Ltd Therapeutic Competitors 62 Oxcarbazepine 62 MEMY 62 TRACON Pharmaceuticals 62 Plaque Psoriasis 62 Cypress Bioscience Inc 62 Momenta Pharma 62 Submits Biologics License Application 62 Receives Orphan Drug 62 Investigational Compound 62 Psivida 62 Vicuron Pharmaceuticals 62 Receives Unsolicited 62 BRILINTA 62 SGXP 62 Q4 Adj 62 Receives Fast Track 62 KV.A 62 Targacept TRGT 62 PDUFA Date 62 Maintains FY# 62 OLGX 62 RhuDex 62 Guides FY# EPS 62 Piper Jaffray Downgrades 62 Announces Share Buyback 62 Pivotal Phase III 62 Nasdaq ACHN 62 R MSCRAMM 62 Jumps Higher 62 Presents Positive Preclinical 62 BioSante Pharmaceuticals Announces 62 Ercole Biotech 62 Nipent R 62 FLDM 62 Aeolus Pharmaceuticals Announces 62 IND Application 62 Somaxon Pharmaceuticals 62 Topiramate Tablets 62 Hydrochlorothiazide Tablets 62 Above Consensus 62 FY# Profit Surges 62 compound KOS 62 Lexapro Effexor Serzone 62 Phase 2a Clinical Trial 62 Pramlintide 62 FDA Accepts 62 Q2 Loss Narrows 62 Guides FY# Update 62 Integra Lifesciences 62 Inc Therapeutic Competitors 62 NEXM 62 Array Biopharma 62 XPEL Announces 62 BPAX 62 CTRX 62 Aldara ® 62 PF # [002] 62 BioSante Pharma 62 Declares Dividend Quick Facts 62 SUPERVALU SVU 62 Aegerion Pharmaceuticals 62 memantine HCl 62 concurrent ITP 62 Silodosin 62 Impax Labs 62 Mg Uk 62 Stiefel Labs 62 Shows Efficacy 62 BioDelivery Sciences 62 KV Pharma 62 IMRX 62 Announce Collaboration Agreement 62 MAP Pharma 62 Ziopharm 62 JAK2 Inhibitor 61 methylphenidate transdermal system 61 Impax Laboratories Inc 61 PSDV 61 H1 Loss Narrows 61 NBIX 61 Begins Clinical Trial 61 Shire plc SHPGY 61 Idera Pharma 61 Gets FDA Clearance 61 R memantine HCl 61 SPRYCEL ® 61 Namenda Memantine HCl 61 includes AstraZeneca Accolate 61 Brovana 61 #mg #mg #mg #mg [002] 61 DepoMed 61 NSTK 61 Lowers Q4 61 Revises FY# 61 markets HP Acthar 61 Teva Provides Update 61 Settle Patent Litigation 61 Boosts Share Buyback 61 Idenix Pharmaceuticals 61 Biodel Inc 61 BUPHENYL R 61 Initiates Clinical Trials 61 Receives Complete Response 61 gets USFDA nod 61 Transcept Pharma 61 NicVAX TM 61 PHARMACEUTICALS 61 XenoPort NASDAQ XNPT 61 Q1 Profit Plunges 61 EPS Beats Estimates 61 Sunesis Pharmaceuticals 61 Phase 2b Clinical Trial 61 NLTX 61 Braintree Laboratories 61 Earnings Surge 61 Bosutinib 61 Ups Guidance 61 Multiple Ascending Dose 61 Trubion Pharma 61 Affirms FY# 61 Drug Shows Promise 61 Systemic Delivery 61 Vion Pharmaceuticals 61 Crofelemer budesonide foam 61 IND Filing 61 Q3 Profit Plummets 61 Forest Labs FRX 61 Piper Jaffray Upgrades 61 RDYN 61 PHARMACEUTICALS INC 61 Kos Pharma 61 Guides FY# 61 Drug Candidate 61 QLTI 61 Updates FY# EPS 61 Pazopanib 61 Pharmos Corporation 61 Piper Jaffray Initiates Coverage 61 Myriad Genetics Inc 61 Preliminary Injunction Against 61 Inc. Nasdaq MITI 61 Questcor Pharma 61 Helps Smokers Quit 61 Immunotherapeutic 61 Pafuramidine 61 markets COLAZAL 61 DRRX 61 OKs Buyback 61 Lifts FY# Revenue 61 Eszopiclone 61 BNVID 61 Lifts FY# 61 Osteoporosis Drug 61 Acacia Subsidiary 61 COLAZAL R 61 Capsules CII 61 Montelukast 61 Backs FY# EPS 61 Chantix Champix 61 Therapeutic Competitors 61 TKPHF 61 Depomed DEPO 61 midstage clinical 61 CRXL 61 Medivation Inc 61 Tesmilifene 61 Migenix 61 Carotid Artery Stenting 61 TransPharma 61 Medicis Pharma 61 First Patient Enrolled 61 Nasdaq PGNX 61 Announce License Agreement 61 oncolytic virus therapies 61 ARIXTRA R 61 RGEN 61 Files Investigational 61 Tipranavir 61 Receives Favorable 61 Rotigotine 61 Lowers FY# EPS 61 Combination REOLYSIN R 61 Transdermal Delivery 61 Alnylam Nasdaq ALNY 61 Zyban bupropion 61 Receives Milestone Payment 61 Phase Ib Clinical Trial 61 Presents Preclinical 61 ZARS Pharma 61 CELGENE 61 Seroquel quetiapine 61 telomerase therapeutic 61 Sumatriptan Succinate 60 EPS Tops Estimate 60 Celera CRA 60 Par Pharmaceutical PRX 60 delivery polymer matrix 60 Vivelle Dot ® 60 TSPT 60 Bearish Speculation 60 VentiRx Pharmaceuticals 60 Tezampanel 60 Guidance Raised 60 Oral Insulin 60 Avanir Pharma 60 Investigational Treatment 60 Lifts Quarterly Dividend 60 OMRIX Biopharmaceuticals 60 OVIT 60 Present Preclinical Data 60 Gets Favorable 60 Completes Enrollment 60 PHASE III 60 Inc. Nasdaq IMGN 60 Drug Combo 60 Nasdaq CADX 60 Interferon beta 1b 60 UGNE 60 SCHEDULED TO PREMIERE 60 Naglazyme R 60 ROSG 60 Submits Supplemental 60 Penwest Pharmaceuticals 60 novel orally inhaled 60 Receives Tentative Approval 60 Upside Purchased 60 Matches Estimate 60 Inc. NASDAQ ICGN 60 Flamel Technologies 60 Receives Orphan Drug Designation 60 fexofenadine HCl 60 Salix Pharmaceuticals Announces 60 Shows Promising 60 Parathyroid Hormone 60 Files Shelf Registration Statement 60 THERAPEUTICS INC 60 Biogen Elan 60 Patient Enrolment 60 Icagen ICGN 60 HP Acthar r 60 Intravenous Formulation 60 Alligator Bioscience AB 60 Miraculins Announces 60 Narrows 4Q Loss 60 Q2 Loss Per 60 Shire Plc SHPGY 60 Cubist Pharmaceuticals CBST 60 MOVIPREP R 60 Array BioPharma 60 Cinacalcet 60 Sustained Release 60 nizatidine 60 Granted Orphan Drug 60 BiolineRX 60 KOSP 60 Cites Positive 60 Fiscal 1Q Profit 60 Cuts FY# EPS 60 MLNM 60 Glaxosmithkline Plc 60 Bremelanotide 60 GTOP 60 Kosan motilin agonist 60 Q2 Profit Slips 60 Citi Downgrades 60 Onyx Pharma 60 Atelvia 60 Custirsen 60 Hikes Dividend 60 Nasdaq ONXX 60 IDEXX Laboratories Announces 60 Initiates Phase 2b 60 Acadia Pharmaceuticals ACAD 60 2A receptor agonist 60 Inc. NASDAQ CBST 60 See CLINICAL PHARMACOLOGY 60 Dia Bras Announces 60 OTCBB PYTO 60 Regains NASDAQ 60 NASDAQ KERX 60 Allergan NYSE AGN 60 Statin Drugs 60 CAMPATH 60 NASDAQ CYTX 60 Biosante Pharmaceuticals 60 Nasdaq IMGN 60 GlaxoSmithKline Imitrex 60 Nasdaq AMAG 60 Q4 Profit Plunges 60 Clavis Pharma ASA 60 PHARMACEUTICALS INC. 60 Idera Pharmaceuticals 60 Zegerid OTC 60 HIV treatments Reyataz 60 Backs FY# Earnings 60 Oncology Compounds 60 Aceon 60 Cholesterol Lowering Drug 60 Ondansetron Orally Disintegrating Tablets 60 Bearish MACD 60 Moving Average Crossover Alert 60 CardioVascular BioTherapeutics 60 AMEX RGN 60 Reaffirms Guidance 60 AstraZeneca AZN.L 行情 60 Xoma Ltd 60 Albugon 60 NASDAQ ENMD 60 Lexicon Pharmaceuticals 60 Etravirine 60 Scolr Pharma 60 http:/www.mffais.com/abt.html 60 zoledronic acid Reclast 60 Nasdaq IDIX 60 Embolic Protection 60 Q3 Profit Plunges 60 Genelabs Technologies 60 Shows Promise Against 60 ANIK 60 Affymax AFFY 60 Initiate Phase 60 Glatiramer Acetate 60 Begins Shipment 60 Nasdaq VNDA 60 Aethlon Medical Releases 60 LSE SHP.L 60 Dose Escalation 60 Aciphex R 60 Ardea Biosciences 59 Quark Biotech 59 CYTC 59 HDAC Inhibitor 59 Habersham Bancorp Announces 59 CYTR 59 #M MarketCap [001] 59 SHR VIEW 59 Taglich Brothers Initiates Coverage 59 Q4 FY# EPS 59 Romiplostim 59 LAS# [002] 59 COVIDIEN 59 Submits IND 59 Actonel risedronate 59 TOP SITES 59 Bupropion HCl ER 59 Puts Sold 59 Pegloticase 59 Boosts Quarterly Dividend 59 SCRX 59 Q2 Profit Drops 59 DVAX 59 Exelon rivastigmine 59 Receives Tentative FDA 59 Obstet Gynecol 59 4Q Profit Slides 59 Prolongs Survival 59 Billion Share Repurchase 59 Transdermal Patch 59 NASDAQ REGN 59 Reports Preclinical Data 59 Bullish Technical Alert 59 generic Viagra Cialis 59 HFA MDI 59 UCB Keppra 59 Aegerion Pharmaceuticals Inc. 59 TRBN 59 Bayer HealthCare Onyx Pharmaceuticals 59 Gets Tentative 59 Crit Rev 59 dutogliptin 59 Revenue Climbs 59 CardioVascular BioTherapeutics Inc. 59 Nasdaq SNSS 59 Roche OTC RHHBY 59 #-# Full Text 59 Syntonix Pharmaceuticals 59 Resubmission 59 AstraZeneca Symbicort 59 ZymoGenetics ZGEN 59 BioMarin Pharmaceutical BMRN 59 Rotavirus Vaccine 59 Sapacitabine 59 Hana Biosciences 59 InNexus Biotechnology 59 ENZN 59 Mln Stock Buyback 59 Æterna Zentaris 59 Anticancer Agent 59 researches develops licenses 59 Nasdaq KERX 59 Neurosurg 59 NASDAQ AVNR 59 INFI 59 Treated Patients 59 KAI Pharmaceuticals Inc. 59 Valera Pharmaceuticals 59 Novel Oral 59 Oxytrol R 59 VCRT 59 NASDAQ ISTA 59 Terbinafine 59 SinuNase ™ 59 Anti Tumor 59 Announces FDA Clearance 59 GENR 59 Critical Therapeutics Zyflo 59 MEVACOR 59 YM Biosciences 59 Entry Levels 59 PharmaVitae Profile 59 BioDelivery 59 Generic Cialis Soft 59 Finacea 59 ZYFLO CR TM 59 treat nicotine addiction 59 Dexilant 59 serotonin norepinephrine reuptake inhibitor 59 Muraglitazar 59 Therapeutic Antibody 59 Nasdaq PARD 59 Welcomes Analyst Initiation 59 PACCAR PCAR 59 reduce serum phosphate 59 Combunox 59 Anticancer Drug 59 ISTA Pharmaceuticals 59 Equetro 59 RockTenn Announces 59 Perforomist ™ Inhalation Solution 59 Orapred ODT 59 Vidaza R 59 Bronchodilator 59 Tablets USP 59 Depakene 59 Q1 Profit Jumps 59 BNVI 59 ESTRASORB ® 59 LUNESTA TM 59 Acorda Therapeutics NASDAQ ACOR 59 Ligand Pharma 59 Nasdaq SPPI 59 Nasdaq AVNR 59 PAION AG 59 Poniard Pharmaceuticals Announces 59 NASDAQ TTHI 59 Myrexis Inc. 59 Biomarin 59 Iloperidone 59 Halozyme Therapeutics 59 Levoleucovorin 59 Desvenlafaxine Succinate 59 nasal calcitonin product 59 Novel Inhibitor 59 Endo Pharmaceuticals ENDP 59 NTII 59 Roche Boniva 59 BIOSCIENCES 59 NRGN 59 Namenda ® 59 Awarded Qualifying Therapeutic 59 vinorelbine tartrate 59 SuperAntibody 59 Januvia sitagliptin 59 Immunomedics Inc 59 Temsirolimus 59 Citracal R 59 Combo Therapy 59 Vitaxin 59 Biomarker Study 59 Tenormin 59 Receives NASDAQ 59 Arch Neurol 59 Posaconazole 59 Million Convertible Debt 59 Connetics Corporation 59 Antigenics NASDAQ AGEN 59 Anadys Pharmaceuticals 59 ENCY 59 NASDAQ OMER 59 NRPH 59 Guidelines Recommend 59 Opns 59 Bearish Average Crossover 59 Option Grants 59 Vildagliptin 59 CyDex Pharmaceuticals 59 ALVESCO R 59 NASDAQ BMRN 59 Doryx 59 olmesartan medoxomil hydrochlorothiazide 59 Restructures Operations 59 SciClone Pharma 59 Pennsaid ® 59 Cephalon NASDAQ CEPH 59 Ultracet R 59 Lowers FY# 59 Perrigo Nasdaq PRGO 59 Backs FY# Revenue 59 IN PATIENTS WITH 59 Favorable Ruling 59 Vaccine Adjuvants 59 # Hydroxycut 59 Raises FY# EPS 59 Sunshine Biopharma 59 s crizotinib ZAH 59 Taligen Therapeutics 59 Solaraze R 59 MIND CTI LTD 59 PCRX 59 NASDAQ PARD 59 SHIRE PLC 59 Nasdaq EPCT 59 CRYO 59 Completes Tender Offer 59 COMUNICADO DE 59 Zemplar Capsules 59 AEterna 59 NASDAQ MOGN 59 Seasonal Influenza Vaccine 59 Increases Buyback 59 HCV Protease Inhibitor 59 Boosts FY# 59 Synta Pharma 59 NASDAQ SCLN 59 Clinical Trial Results 59 Tightens FY# 59 UBS Maintains Buy 59 DOWNTREND CALL 59 Nasdaq CTIC 59 Trims Loss 59 SABESP Announces 59 Presents Preclinical Data 59 Makes Bearish 59 PDE4 inhibitor 59 Inc. Nasdaq NEOL 59 Initiated Phase 59 Hydrochloride Tablets 59 AvalonBay Communities Announces 59 United Therapeutics UTHR 59 ARCA Biopharma 59 Threshold Pharmaceuticals 59 ABLYNX 59 Carrols Restaurant 59 ONCY 59 Medoro Resources Announces 59 NexMed Receives 59 Reaffirms FY 59 Vitrasert R 59 Myriad Genetics NASDAQ MYGN 59 Levaquin levofloxacin 59 DAYTRANA TM 59 CIMYM 59 Inc POZN 59 Dabigatran etexilate 59 Patent Infringement Litigation 58 Inc. NASDAQ ZLCS 58 CorVel Announces 58 Catalyst Biosciences 58 Tamoxifen Citrate 58 Zovirax acyclovir 58 Biogen NASDAQ BIIB 58 Lilly Cymbalta 58 Hsp# Inhibitor 58 DepoCyt ® Abelcet ® 58 Intravitreal 58 #mg #mg #mg [003] 58 EYET 58 Eyetech Pharmaceuticals 58 please visit http:/www.vandapharma.com 58 Generic Propecia 58 developing Zerenex ferric 58 Clinical Trial Data 58 NASDAQ PCYC 58 Announce Licensing Agreement 58 Xenazine ® 58 NovaBay Pharmaceuticals 58 #mg #mg #mg [001] 58 MRNA 58 PROTONIX 58 Nasdaq CYCC 58 Nasdaq IPXL 58 Tigecycline 58 Biovail BVF 58 Fondaparinux 58 EPS Rises 58 vapreotide acetate 58 Sycrest 58 Nascobal ® 58 Q3 Profit Climbs 58 HuMax 58 Submits Application 58 Narrows FY# EPS 58 Nasdaq PHRM 58 Betaferon R 58 SYCREST 58 ANN INTERN MED 58 Maintains Hold 58 Aflibercept 58 Zorbtive TM 58 Phase III Clinical Trial 58 balsalazide tablet 58 oral salmon calcitonin 58 Novel Antibiotic 58 Percutaneous Tibial Nerve Stimulation 58 Cytokinetics CYTK 58 sirtuin modulators 58 Antisoma plc 58 By JAMAAL ABDUL 58 Stedesa 58 Encision Reports 58 Rejects Unsolicited 58 Ganciclovir 58 GlaxoSmithKline Tykerb 58 Endo Pharma 58 Q3 Profit Jumps 58 Pravachol pravastatin 58 ViroPharma NASDAQ VPHM 58 Study Shows Benefits 58 Study Evaluating 58 QLT NASDAQ QLTI 58 CRGN 58 Bristol Myers Squibb Pravachol 58 Confirmatory Phase 58 Patent Infringement Lawsuit Against 58 NASDAQ UNIS 58 Protalix BioTherapeutics AMEX PLX 58 Explores Strategic Alternatives 58 Therapeutic Vaccine 58 successfully commercialize Iluvien 58 MAKO Surgical 58 PWRM.OB 58 Adventrx 58 Inc SPPI 58 Perrigo PRGO 58 Xanthus Pharmaceuticals Inc. 58 ARDM 58 Oral Laquinimod 58 Outlook Disappoints 58 XTL Biopharmaceuticals Ltd. 58 HCV polymerase 58 REVEAL Registry 58 Phase IIa Clinical Trial 58 Private Equity Financing 58 UBS Maintains Neutral 58 Pfizer Norvasc 58 Entremed 58 4Q Loss Widens 58 Neurobiological 58 RAZADYNE 58 Sepracor SEPR 58 Investigational Oral 58 Adjunctive Therapy 58 Airmedia Group Inc 58 Genelabs Technologies Inc. 58 Warner Chilcott WCRX 58 Adjuvant Treatment 58 Enzon Pharmaceuticals ENZN 58 Wyeth Enbrel 58 Nasdaq MBRX 58 visit http:/www.mannkindcorp.com 58 Welichem 58 PD Rx 58 LAB CGRP 58 CIP TRAMADOL ER 58 TSRX 58 CNMD 58 Receives Conditional 58 Kinase Inhibitor 58 Single Dose 58 Somatuline Autogel 58 Anidulafungin 58 Clinical Trials Update 58 NASDAQ Listing Requirements 58 AstraZeneca Targacept 58 Paladin Labs 58 Sanofi NYSE SNY 58 Frova ® 58 Nasdaq REGN 58 CORX 58 Novel Protein 58 Extends Collaboration 58 Empatic ™ 58 LEVADEX TM 58 TO AVOID PREGNANCY WHILE 58 UNDER PRESSURE DOWN 58 Novartis Trileptal 58 ONCONASE ranpirnase 58 Novartis Femara 58 QTXB 58 Fenoglide 58 Syndax Pharmaceuticals Inc. 58 Arixtra ® 58 Repros Therapeutics Inc 58 Affirms Guidance 58 Synthetic Peptide 58 acyclovir Lauriad R 58 CNS Disorders 58 NRMX 58 Glatiramer acetate 58 lovastatin Mevacor 58 Elagolix 58 NASDAQ CYPB 58 Nasdaq MYGN 58 Lopressor 58 ALNY 58 pioglitazone hydrochloride 58 Ramelteon 58 Enters Oversold Territory 58 Cardiotoxicity 58 Reaffirms Earnings 58 Ventrus 58 OTC Zegerid 58 MOGN 58 Nymox Reports 58 Avanir Pharmaceuticals Inc 58 Announces Poster Presentations 58 Isis Pharmaceuticals ISIS 58 FOR FURTHER INFORMATION ABOUT 58 Integrase Inhibitor 58 Pharmacokinetic Study 58 Oxymorphone ER 58 Treat Anemia 58 Exelixis EXEL 58 ORAL Sync 58 Momenta Pharmaceuticals Inc 58 NASDAQ ALXA 58 Demonstrate Significant 58 SCLN 58 RELOVAIR ™ 58 IVGN 58 glucokinase activator 58 TELINTRA R 58 NASDAQ MIPI 58 NASDAQ BIOD 58 Zolpimist ™ 58 Targretin capsules 58 Lovaza TM 58 Novartis VIRT X 58 neuronal nicotinic receptor NNR 58 Axid 58 J Pediatr 58 Takeda Pharma 58 Increases Share Repurchase 58 Xeloda ® 58 Ticagrelor 58 BioMimetic Therapeutics BMTI 58 Nasdaq CRTX 58 Submits Investigational 58 Simvastatin Tablets 58 Arthritis Drugs 58 CADX 58 Meritage Pharma 58 NICE Recommends 58 Randomized Clinical Trials 58 Therapy Improves 58 Revises Q4 58 Improves Survival 58 FS Antihemophilic Factor Recombinant 58 Bullish Speculation 58 Sign License Agreement 58 AMEX PLX 58 Diabetic Foot Ulcer 58 Accentia Biopharmaceuticals 58 Loss Narrows Quick Facts 58 LymphoStat B belimumab 58 Combination Treatment 58 Angiotech Pharmaceuticals ANPI 58 Phusion Laboratories 57 risedronate sodium tablets 57 Randomized Phase II 57 TLCR 57 Crowflight Announces 57 products Oncaspar ® 57 Recurrent Glioblastoma 57 DR Tablets 57 Oroco Announces 57 Guidance Reaffirmed 57 Injection Site 57 Nasdaq Delisting 57 Sular ® 57 Anticonvulsant 57 Progenics Pharmaceuticals 57 Cypress Bioscience 57 1mg 2mg 57 THLD 57 Savient Pharma 57 Severe Sepsis 57 AirIQ Announces 57 Celgene Revlimid 57 azelastine hydrochloride 57 ELGX 57 Mimetics 57 Ortho Cept 57 NASDAQ INFI 57 Nasdaq RXII 57 Abraxis Bioscience Inc. 57 CROCS CROX 57 AFREZZA TM 57 Biodel NASDAQ BIOD 57 cosmetic cosmeceutical products 57 Registration Statement Declared Effective 57 HIV integrase inhibitor 57 Cinacalcet HCl 57 GlaxoSmithKline Lamictal 57 Levetiracetam 57 Venlafaxine 57 AMD# [002] 57 VTUS 57 NDQ 57 Boosts FY# EPS 57 Optimer Pharmaceuticals Inc 57 Q1 FY# EPS 57 Vernalis plc 57 Previously Disclosed 57 MetroGel R 57 Nasdaq AVNC 57 brand ciclesonide HFA 57 Barr Receives Approval 57 Eli Lilly Cymbalta 57 selective estrogen receptor modulator 57 Inc. Nasdaq OXGN 57 NYSE Amex RNN 57 Ameris Bancorp ABCB 57 Finerman Firm Owns 57 AG NVS 57 Maleate 57 R brand eszopiclone 57 PDL BioPharma NASDAQ PDLI 57 OMAPRO ™ 57 Innerworkings Inc INWK 57 ZYFLO R 57 Novartis AG Foradil 57 Celldex Therapeutics CLDX 57 Mature Trend #.# 57 Weight Loss Pill 57 Transkaryotic Therapies TKTX 57 INTUNIV TM 57 Bipolar Depression 57 LEVAQUIN ® 57 Jobless Claims Climb 57 SUTENT ® 57 Levels Linked 57 Altus Pharmaceuticals 57 Disease Modifying 57 AMEX DDD 57 StanCorp Financial 57 Receives Positive Opinion 57 Reaffirms Fiscal 57 Chemokine 57 Zoloft sertraline 57 Qiagen NASDAQ QGEN 57 Boosts Dividend